SCHEMBL4779160

SCHEMBL4779160

COC(=O)c1cccc2ncc(-c3ccc(Cl)cc3)nc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.60
SLC6A4 P31645 1/20 0.53
SLC6A3 Q01959 1/20 0.53
MAPT P10636 4/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PARP2 Q9UGN5 1/20 0.52
KMT2A Q03164 4/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
ATM Q13315 1/20 0.47
PLA2G2A P14555 2/20 0.45
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4779209 0.90 PARP1 (0.71) PARP1SLC6A4SLC6A3MAPTNPC1
SCHEMBL7044628 0.88 PARP1 (0.60) PARP1SLC6A3MAPTNPC1RAB9A
SCHEMBL424209 0.83 PARP1 (0.81) PARP1NPC1RAB9ASMN1; SMN2PARP2
SCHEMBL31602072 0.83 PARP1 (0.81) PARP1NPC1RAB9ASMN1; SMN2PARP2
SCHEMBL4777457 0.81 PARP1 (0.58) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL21638317 0.77 KDM4E (0.55) PARP1NPC1RAB9AL3MBTL1KMT2A
SCHEMBL7045177 0.75 PARP1 (1.00) PARP1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL71209 0.74 KDM4E (0.74) MAPTKMT2AKDM4EGAAATM
SCHEMBL25168918 0.74 KDM4E (0.61) SLC6A4SLC6A3MAPTSMN1; SMN2KMT2A
SCHEMBL27963658 0.73 HPGD (0.64) MAPTNPC1RAB9ASMN1; SMN2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008015429-A2 PHARMACEUTICAL COMPOUNDS SENTINEL ONCOLOGY LIMITED (GB) 2008-02-07 WO disclosed
WO-2008015429-A2 PHARMACEUTICAL COMPOUNDS SENTINEL ONCOLOGY LIMITED (GB) 2008-02-07 WO disclosed